Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mittendorf

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Diabetes, Obesity & Metabolism|September 8, 2009
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German settingT Mittendorf, J Smith-Palmer, L Timlin, et al.
Deutsche Medizinische Wochenschrift (1946)|February 11, 2010
[Costs of ulcerative colitis within the German Statutory Health Insurance]A Prenzler, B Bokemeyer, T Mittendorf, et al.
Zeitschrift Fur Gastroenterologie|July 17, 2009
[Costs of Crohn's disease in Germany from the perspective of the Statutory Health Insurance]A Prenzler, T Mittendorf, S Conrad, et al.
Zeitschrift Fur Rheumatologie|March 15, 2006
[Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components]S Merkesdal, J L Huelsemann, T Mittendorf, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Economic evaluation of human papillomavirus screening in GermanyT Mittendorf, K U Petry, T Iftner, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Conceptual and methodological basics of cost assessments in rheumatology]J Ruof, J L Hülsemann, T Mittendorf, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Implementing standardized cost categories within economic evaluations in musculoskeletal diseasesT Mittendorf, S Merkesdal, J L Huelsemann, et al.
Rheumatology (Oxford, England)|January 5, 2008
Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspectiveT Mittendorf, B Dietz, R Sterz, et al.
Deutsche Medizinische Wochenschrift (1946)|November 13, 2014
[Evolution of biologicals in inflammation medicine--biosimilars in gastroenterology, rheumatology and dermatology]S Schreiber, T Luger, T Mittendorf, et al.
Neurology|October 6, 2010
Assessment of potential measures in models of progression in Alzheimer diseaseT McLaughlin, M Buxton, T Mittendorf, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Diabetes, Obesity & Metabolism|September 8, 2009
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German settingT Mittendorf, J Smith-Palmer, L Timlin, et al.
Deutsche Medizinische Wochenschrift (1946)|February 11, 2010
[Costs of ulcerative colitis within the German Statutory Health Insurance]A Prenzler, B Bokemeyer, T Mittendorf, et al.
Zeitschrift Fur Gastroenterologie|July 17, 2009
[Costs of Crohn's disease in Germany from the perspective of the Statutory Health Insurance]A Prenzler, T Mittendorf, S Conrad, et al.
Zeitschrift Fur Rheumatologie|March 15, 2006
[Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components]S Merkesdal, J L Huelsemann, T Mittendorf, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Economic evaluation of human papillomavirus screening in GermanyT Mittendorf, K U Petry, T Iftner, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Conceptual and methodological basics of cost assessments in rheumatology]J Ruof, J L Hülsemann, T Mittendorf, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Implementing standardized cost categories within economic evaluations in musculoskeletal diseasesT Mittendorf, S Merkesdal, J L Huelsemann, et al.
Rheumatology (Oxford, England)|January 5, 2008
Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspectiveT Mittendorf, B Dietz, R Sterz, et al.
Deutsche Medizinische Wochenschrift (1946)|November 13, 2014
[Evolution of biologicals in inflammation medicine--biosimilars in gastroenterology, rheumatology and dermatology]S Schreiber, T Luger, T Mittendorf, et al.
Neurology|October 6, 2010
Assessment of potential measures in models of progression in Alzheimer diseaseT McLaughlin, M Buxton, T Mittendorf, et al.
Pageof 3